INOSINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C10H12N4O5
Molecular Weight	268.2261
Optical Activity	UNSPECIFIED
Defined Stereocenters	4 / 4
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of INOSINE

Structure Search

SMILES

OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CNC3=O

InChI

InChIKey=UGQMRVRMYYASKQ-KQYNXXCUSA-N

InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C10H12N4O5
Molecular Weight	268.2261
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	4 / 4
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 17:32:52 UTC 2023` Edited by `admin` on `Sat Dec 16 17:32:52 UTC 2023`
Record UNII	5A614L51CT
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

INOSINE

Official Name

English

HYPOXANTHINE RIBOSIDE

Common Name

English

INOSINE [MART.]

Common Name

English

9-.BETA.-D-RIBOFURANOSYL-1,9-DIHYDRO-6H-PURIN-6-ONE

Systematic Name

English

inosine [INN]

Common Name

English

9-.BETA.-D-RIBOFURANOSYLHYPOXANTHINE

Common Name

English

INOSINE [MI]

Common Name

English

DIDANOSINE IMPURITY B [EP IMPURITY]

Common Name

English

INOSINE [WHO-IP]

Common Name

English

INOSINE [JAN]

Common Name

English

INOSINE [INCI]

Common Name

English

NSC-20262

Code

English

INOTIN

Brand Name

English

9-.BETA.-D-RIBOFURANOSYL-1,9-DIHYDRO-6H-PURIN-6-ONE [WHO-IP]

Common Name

English

HYPOXANTHOSINE

Common Name

English

INOSINE [USP IMPURITY]

Common Name

English

ADENOSINE IMPURITY G [EP IMPURITY]

Common Name

English

DIDANOSINE IMPURITY B [WHO-IP]

Common Name

English

Inosine [WHO-DD]

Common Name

English

Classification Tree Code System Code

WHO-VATC

QG01AX02

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

WHO-ATC

G01AX02

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

LOINC

59210-5

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

WHO-ATC

S01XA10

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

WHO-ATC

D06BB05

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

WHO-VATC

QS01XA10

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

LOINC

75154-5

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

LOINC

75150-3

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

WHO-VATC

QD06BB05

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

LOINC

2479-4

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

DSLD

1774 (Number of products:41)

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

Code System Code Type Description

FDA UNII

5A614L51CT

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

DAILYMED

5A614L51CT

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

EVMPD

SUB08191MIG

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

WIKIPEDIA

Inosine

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

DRUG CENTRAL

3301

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

RXCUI

1483575

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

RxNorm

ECHA (EC/EINECS)

200-390-4

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

CAS

58-63-9

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

DRUG BANK

DB04335

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

INN

4687

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

MERCK INDEX

m6288

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

Merck Index

NCI_THESAURUS

C166836

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

ChEMBL

CHEMBL1556

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

PUBCHEM

135398641

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

CHEBI

17596

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

SMS_ID

100000083399

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

NSC

20262

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

MESH

D007288

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

EPA CompTox

DTXSID2045993

Created by admin on Sat Dec 16 17:32:53 UTC 2023 , Edited by admin on Sat Dec 16 17:32:53 UTC 2023

PRIMARY

Related Record Type Details


					W1SO0V223F

INOSINE PRANOBEX

SALT/SOLVATE -> PARENT

Amount:

Related Record Type Details


					K72T3FS567

ADENOSINE

PARENT -> METABOLITE

Comments:

Adenosine is broken down by adenosine deaminase, which is present in red cells and the vessel wall.

Interaction Type:

MAJOR

Related Record Type Details


					K3GDH6OH08

PARENT -> IMPURITY

Comments:

The area of any individual peak corresponding to impurity B is not greater than 0.2 times the area of the principal peak obtained with solution (4) (0.2%).

Amount:


					K72T3FS567

ADENOSINE

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

USP

Amount:


					K72T3FS567

ADENOSINE

PARENT -> IMPURITY

Comments:

correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity A = 0.6; impurity G = 1.4

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:

Related Record Type Details


					5A614L51CT

INOSINE

ACTIVE MOIETY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount: